HORMONAL TREATMENTS FOR PREMENSTRUAL-SYNDROME

Citation
Em. Kouri et U. Halbreich, HORMONAL TREATMENTS FOR PREMENSTRUAL-SYNDROME, Medicamentos de actualidad, 34(7), 1998, pp. 603-610
Citations number
73
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
00257656
Volume
34
Issue
7
Year of publication
1998
Pages
603 - 610
Database
ISI
SICI code
0025-7656(1998)34:7<603:HTFP>2.0.ZU;2-C
Abstract
Ovarian function appears to play a fundamental role in premenstrual sy ndrome (PMS). Accordingly treatment strategies designed to suppress ov ulation have generally been found to be effective for treatment of men strually related syndromes and symptoms. GnRH agonists and Danazol(R) are probably inferior to estrogen, due to their unfavorable side effec ts profile. In addition, it is worthwhile to emphasize that in spite o f the publicity of progesterone treatment for PMS, in most well-contro lled studies it has not been shown to be more effective than placebo f or the treatment of these syndromes. The efficacy of hormonal treatmen ts that do not suppress ovulation is still controversial. (C) 1998 Pro us Science. All rights reserved.